HEALEY ALS Trial Serves Up More Disappointment as Denali, AbbVie/Calico Fail
Misses from amyotrophic lateral sclerosis hopefuls Denali Therapeutics and partners AbbVie and Calico Life Sciences mark the latest setbacks for the controversial platform trial, the results from which have largely mirrored the dismal success rate in ALS overall.
In response to the devastating fires raging in LA, a small restaurant in Surf City USA has become a channel for big help — ...
The company said Monday that fosigotifator failed to outperform placebo in slowing the neurodegenerative disease, but is ...
AbbVie, Calico and Denali Therapeutics’ hopes of treating amyotrophic lateral sclerosis (ALS) by targeting eIF2B have all ...
Calico ignited the race by drug companies to find treatments for aging-related diseases. An ALS-fighting drug from Calico Life Sciences LLC — the Alphabet-backed anti-aging company founded by ...
STAT reporters discuss why a looming patent cliff could lead to more pharmaceutical deal-making and a new obesity startup.
In studies by Massachusetts General Hospital, the AbbVie-Calico collaborative drug and Denali Therapeutics' own drug failed to meet endpoints for treating amyotrophic lateral sclerosis, more widely ...
The grand opening of Scott Moore’s new venture, Calico Cactus, A Modern Taco Shop, in St. Augustine, is schedule for Jan. 14.
Small businesses in Los Angeles and the surrounding counties have offered help to people affected by the fires raging in the Pacific Palisades as well as the San Fernando and San Gabriel Valleys. Here ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback